7th Innate Killer Summit (San Diego, California)
Cartherics Chief Development Officer, Dr Nicholas Boyd
The innate cell therapy field is exploding as novel research charges through the clinic, proving its potential as a safe, efficacious, and cost-effective treatment. From 30 March-1 April 2022 Pacific Daylight Time (PDT) industry experts will meet in San Diego, California to discuss […]
The 4th Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical development, translation, manufacturing, supply and storage of allogeneic cell therapies to improve the accessibility and efficacy of patient care worldwide.
400+ experts from pharma, biotech and leading academia are expected to attend in Boston, USA […]
Presentation at the Next Generation CAR-TCR Summit (London, UK)
Cartherics Chief Development Officer, Dr Nicholas Boyd
CAR-T immunotherapy has exploded over the last half a decade. It is now a billion-dollar market that is expanding rapidly with over 400+ new cell therapy trials in 2021 alone. But challenges still remain in solid tumours, toxicity management and manufacturing […]
Chief Development Officer, Dr Nicholas Boyd
Cell therapies have the potential to not only be life-saving but curative for a host of diseases. However, inherent limitations in autologous based CAR-T therapy face major roadblocks for mass adoption and therapeutic effects in solid tumour indications.
On Friday 28 January at 7:30 am AEDT Nicholas will discuss the design, […]
By Leigh Dayton
27 August 2021
Cartherics CEO Alan Trounson congratulates Natalia Benetti for her important research in developmental cell biology: “It’s great work and very well presented”.
The company also applauds the Australian Regenerative Medicine Institute for successfully organising the 13th Victorian State Conference of the […]
By Leigh Dayton
22 July 2021
Cartherics is delighted to announce that it is a sponsor of the Australia and New Zealand Society of Cell and Developmental Biology’s Victorian State Conference. The highly regarded one-day event is booked for 26 August at the University of Melbourne.
Cartherics CEO Alan Trounson welcomes the opportunity to support the meeting.
“It is […]
By Leigh Dayton
11 June 2021
Alan Trounson joined a day-long discussion on advances in regenerative medicine. The virtual event brought together the world’s leading experts.
At the session on emerging immuno-oncology, Trounson told delegates that Cartherics believes its novel CAR-T and CAR-NK cells have great potential […]
It all happened at Cape Schanck ……
By Leigh Dayton
24 February 2021
2020 was a rough year everywhere for everyone, including Cartherics’ hard-working team. By way of a thank you CEO Alan Trounson, Chairman Bob Moses and Chief Operating Officer Ian Nisbet hosted a company come-one come-all event this month at the Royal Automobile Club […]
18 November 2020
By Leigh Dayton
They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.
Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]
By Leigh Dayton
8 July 2020
Cartherics will take part in the Onco Cell Therapy Summit 2020 virtual conference 8-10 July AEST. Cartherics CEO Alan Trounson, Chief Scientific Officer Richard Boyd and lead scientists will join an international gathering of key decision makers for CAR-T therapies.
The Summit, […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
